Phase NA × Completed × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Clear all Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
Phase NA Completed
30 enrolled
BMT
Phase NA Completed
10 enrolled
Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Phase NA Completed
13 enrolled
A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia
Phase NA Completed
30 enrolled
MargheRITA
Phase NA Completed
124 enrolled
The EMPATHY Pilot Study
Phase NA Completed
94 enrolled 13 charts
DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer
Phase NA Completed
25 enrolled
A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
Phase NA Completed
47 enrolled
Mini-allo
Phase NA Completed
36 enrolled
Unrelated Donor Stem Cell Transplantation
Phase NA Completed
64 enrolled
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Phase NA Completed
281 enrolled 24 charts
CAR-LMC
Phase NA Completed
53 enrolled
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
Phase NA Completed
125 enrolled 9 charts
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention
Phase NA Completed
48 enrolled 7 charts
IM-TMI
Phase NA Completed
14 enrolled 14 charts
Unrelated Umbilical Cord Blood (UBC)Transplantation
Phase NA Completed
34 enrolled 10 charts
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Phase NA Completed
18 enrolled 7 charts
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Phase NA Completed
8 enrolled 12 charts
Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality of Life
Phase NA Completed
99 enrolled
TAR
Phase NA Completed
7 enrolled 8 charts
Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy
Phase NA Completed
876 enrolled
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
Phase NA Completed
41 enrolled
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
Phase NA Completed
68 enrolled
Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients
Phase NA Completed
129 enrolled
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
Phase NA Completed
100 enrolled 10 charts
STIM 2
Phase NA Completed
220 enrolled
Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
Phase NA Completed
40 enrolled
TAKE-IT
Phase NA Completed
58 enrolled
An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Phase NA Completed
8 enrolled
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
Phase NA Completed
Natural Killer Index From Hematopoietic Stem Cell Graft
Phase NA Completed
92 enrolled
Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors
Phase NA Completed
33 enrolled
STIM
Phase NA Completed
100 enrolled
Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
Phase NA Completed
120 enrolled
Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients
Phase NA Completed
10 enrolled
GLIFERTI
Phase NA Completed
2 enrolled